These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28337562)

  • 1. BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression.
    Alcarraz-Vizán G; Castaño C; Visa M; Montane J; Servitja JM; Novials A
    Cell Mol Life Sci; 2017 Aug; 74(15):2827-2838. PubMed ID: 28337562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of BACE2 counteracts hIAPP-induced insulin secretory defects in pancreatic β-cells.
    Alcarraz-Vizán G; Casini P; Cadavez L; Visa M; Montane J; Servitja JM; Novials A
    FASEB J; 2015 Jan; 29(1):95-104. PubMed ID: 25342134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha1-antitrypsin ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction.
    Rodríguez-Comas J; Moreno-Vedia J; Obach M; Castaño C; de Pablo S; Alcarraz-Vizán G; Díaz-Catalán D; Mestre A; Horrillo R; Costa M; Novials A; Servitja JM
    Mol Metab; 2020 Jul; 37():100984. PubMed ID: 32229246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Human Islet Amyloid Polypeptide as a BACE2 Substrate.
    Rulifson IC; Cao P; Miao L; Kopecky D; Huang L; White RD; Samayoa K; Gardner J; Wu X; Chen K; Tsuruda T; Homann O; Baribault H; Yamane H; Carlson T; Wiltzius J; Li Y
    PLoS One; 2016; 11(2):e0147254. PubMed ID: 26840340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes.
    Kim J; Cheon H; Jeong YT; Quan W; Kim KH; Cho JM; Lim YM; Oh SH; Jin SM; Kim JH; Lee MK; Kim S; Komatsu M; Kang SW; Lee MS
    J Clin Invest; 2014 Aug; 124(8):3311-24. PubMed ID: 25036705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.
    Chen YC; Mains RE; Eipper BA; Hoffman BG; Czyzyk TA; Pintar JE; Verchere CB
    Diabetologia; 2020 Mar; 63(3):561-576. PubMed ID: 31984442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA1 deficiency and cellular cholesterol accumulation increases islet amyloidogenesis in mice.
    Wijesekara N; Kaur A; Westwell-Roper C; Nackiewicz D; Soukhatcheva G; Hayden MR; Verchere CB
    Diabetologia; 2016 Jun; 59(6):1242-6. PubMed ID: 26970755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of cholesterol homeostasis is an early signal of β-cell proteotoxicity characteristic of type 2 diabetes.
    Gurlo T; Liu R; Wang Z; Hoang J; Ryazantsev S; Daval M; Butler AE; Yang X; Blencowe M; Butler PC
    Physiol Genomics; 2024 Sep; 56(9):621-633. PubMed ID: 38949617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of human tau and islet amyloid polypeptide exacerbates metabolic dysfunction in transgenic mice.
    Wijesekara N; Gonçalves RA; Ahrens R; Ha K; De Felice FG; Fraser PE
    J Pathol; 2021 Jul; 254(3):244-253. PubMed ID: 33797777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human islet amyloid polypeptide transgenic mice: in vivo and ex vivo models for the role of hIAPP in type 2 diabetes mellitus.
    Höppener JW; Jacobs HM; Wierup N; Sotthewes G; Sprong M; de Vos P; Berger R; Sundler F; Ahrén B
    Exp Diabetes Res; 2008; 2008():697035. PubMed ID: 18497871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-induced β-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment.
    Montane J; de Pablo S; Castaño C; Rodríguez-Comas J; Cadavez L; Obach M; Visa M; Alcarraz-Vizán G; Sanchez-Martinez M; Nonell-Canals A; Parrizas M; Servitja JM; Novials A
    FASEB J; 2017 Dec; 31(12):5296-5306. PubMed ID: 28821639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells.
    Chatterjee Bhowmick D; Jeremic A
    J Biol Chem; 2018 Sep; 293(37):14210-14223. PubMed ID: 30012886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
    Templin AT; Mellati M; Soininen R; Hogan MF; Esser N; Castillo JJ; Zraika S; Kahn SE; Hull RL
    Protein Eng Des Sel; 2019 Dec; 32(2):95-102. PubMed ID: 31769491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in β-cells: evidence of interplay between the ubiquitin/proteasome system and autophagy.
    Costes S; Gurlo T; Rivera JF; Butler PC
    Autophagy; 2014 Jun; 10(6):1004-14. PubMed ID: 24879150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes.
    Mukherjee N; Contreras CJ; Lin L; Colglazier KA; Mather EG; Kalwat MA; Esser N; Kahn SE; Templin AT
    Mol Metab; 2024 Feb; 80():101877. PubMed ID: 38218538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bace2 is a β cell-enriched protease that regulates pancreatic β cell function and mass.
    Esterházy D; Stützer I; Wang H; Rechsteiner MP; Beauchamp J; Döbeli H; Hilpert H; Matile H; Prummer M; Schmidt A; Lieske N; Boehm B; Marselli L; Bosco D; Kerr-Conte J; Aebersold R; Spinas GA; Moch H; Migliorini C; Stoffel M
    Cell Metab; 2011 Sep; 14(3):365-77. PubMed ID: 21907142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
    Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
    Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets.
    Meier DT; Entrup L; Templin AT; Hogan MF; Mellati M; Zraika S; Hull RL; Kahn SE
    Diabetologia; 2016 Oct; 59(10):2166-71. PubMed ID: 27393137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity.
    de Pablo S; Rodríguez-Comas J; Díaz-Catalán D; Alcarraz-Vizán G; Castaño C; Moreno-Vedia J; Montane J; Parrizas M; Servitja JM; Novials A
    Sci Rep; 2021 Jun; 11(1):11878. PubMed ID: 34088954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.